ArticleMolecular therapy. Nucleic acids2023

Sustained therapeutic benefits by transient reduction of TDP-43 using ENA-modified antisense oligonucleotides in ALS/FTD mice.

Toshihide Takeuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.